-

Smart Medical Devices Business Analysis Report 2024: Global Market to Reach $67.4 Billion by 2030 - Telehealth Platforms, Wearable Sensors, and Digital Health Apps Expands Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Smart Medical Devices - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global market for Smart Medical Devices was estimated at US$33.7 Billion in 2023 and is projected to reach US$67.4 Billion by 2030, growing at a CAGR of 10.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the Smart Medical Devices market is driven by several factors, including increasing adoption of digital health solutions, which emphasize remote patient monitoring and chronic disease management. Advancements in sensor technology, wireless connectivity, and AI-based data analytics have enhanced the accuracy and functionality of smart medical devices, supporting wider use in preventive and personalized medicine.

The growing prevalence of chronic diseases like diabetes, hypertension, and respiratory disorders has further fueled demand for smart medical devices that enable continuous monitoring and timely intervention. Additionally, government initiatives promoting telemedicine and digital healthcare have contributed to market expansion, as healthcare providers and patients seek innovative solutions for efficient and effective care delivery.

How Are Smart Medical Devices Transforming Healthcare Delivery?

Smart medical devices are connected healthcare tools that provide real-time patient monitoring, diagnostics, and treatment management. Equipped with sensors, IoT connectivity, and data analytics, these devices offer enhanced accuracy, remote monitoring capabilities, and integration with electronic health records (EHR). From wearable fitness trackers and glucometers to implantable devices and smart inhalers, smart medical devices support personalized medicine, telemedicine, and proactive health management. As healthcare systems shift toward digital transformation, smart medical devices have become essential for improving patient outcomes, reducing hospital visits, and enhancing overall care quality.

What Are the Key Segments in the Smart Medical Devices Market?

Key device types include diagnostic devices, monitoring devices, and therapeutic devices, with monitoring devices holding the largest market share due to their role in chronic disease management and telehealth. Applications span diabetes care, respiratory monitoring, cardiovascular monitoring, and fitness tracking, with diabetes care representing a significant segment driven by the need for continuous glucose monitoring (CGM) and insulin management. End-users include hospitals, clinics, and home care, with home care leading the market as patients adopt self-monitoring and remote management tools.

How Are Smart Medical Devices Integrated Across Healthcare?

In hospitals, smart medical devices like infusion pumps, ECG monitors, and ventilators provide real-time patient data, enabling timely interventions and improved care. In home care, devices like smart glucometers, pulse oximeters, and blood pressure monitors support patients in managing chronic conditions while sharing data with healthcare providers through connected apps. Wearable devices like smartwatches and fitness trackers offer users insights into physical activity, heart rate, and sleep patterns, promoting overall wellness. Additionally, telemedicine platforms use data from smart medical devices to facilitate remote consultations, diagnostics, and treatment adjustments, supporting continuity of care.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Smart Medical Devices Market such as Abbott Laboratories, Apple Inc., Dexcom, Inc., Everist Genomics, F. Hoffmann-La Roche Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Diagnostics & Monitoring Devices segment, which is expected to reach US$44.6 Billion by 2030 with a CAGR of a 10.1%. The Therapeutic Devices segment is also set to grow at 11.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $9.3 Billion in 2023, and China, forecasted to grow at an impressive 9.6% CAGR to reach $10.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Key Attributes:

Report Attribute Details
No. of Pages 89
Forecast Period 2023 - 2030
Estimated Market Value (USD) in 2023 $33.7 Billion
Forecasted Market Value (USD) by 2030 $67.4 Billion
Compound Annual Growth Rate 10.4%
Regions Covered Global

Key Topics Covered:

MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Smart Medical Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

MARKET TRENDS & DRIVERS

  • Rising Focus on Digital Healthcare Spurs Growth in Smart Medical Devices
  • Technological Advancements in AI, IoT, and Cloud-Based Monitoring Strengthen Business Case for Smart Devices
  • Increasing Adoption in Remote Patient Monitoring, Chronic Disease Management, and Elderly Care Expands Market
  • Expansion of Smart Devices in Cardiovascular, Respiratory, and Neurological Monitoring Fuels Growth
  • Growing Demand for Real-Time Health Insights, Alerts, and Predictive Analytics Drives Adoption
  • Integration with Telehealth Platforms, Wearable Sensors, and Digital Health Apps Expands Addressable Market
  • Rising Focus on Personalized, Data-Driven, and Continuous Monitoring Generates New Demand
  • Technological Innovations in Miniaturization, Biocompatibility, and Battery Life Propel Market Growth
  • Growing Use of Smart Medical Devices in Home Healthcare, Post-Surgical Recovery, and Rehab Expands Market
  • Focus on Achieving Compliance with HIPAA, GDPR, and Medical Device Directives Strengthens Adoption
  • Rising Demand for AI-Driven Diagnostics, Self-Tracking, and Digital Therapeutics Generates Market Opportunities
  • Technological Advancements in Wearable, Implantable, and Connected Medical Devices Propel Market Expansion
  • Growing Demand for Safe, Accurate, and Non-Invasive Health Monitoring Drives Adoption

FOCUS ON SELECT PLAYERS: Some of the 33 companies featured in this Global Smart Medical Devices market report include

  • Abbott Laboratories
  • Apple Inc.
  • Dexcom, Inc.
  • Everist Genomics
  • F. Hoffmann-La Roche Ltd.
  • Fitbit, Inc.
  • Johnson & Johnson
  • Medtronic plc.
  • NeuroMetrix, Inc.
  • Omron Corporation
  • Philips Electronics
  • Samsung Electronics Co., Ltd
  • Sonova
  • Sotera Wireless
  • Vital Connect
  • Zephyr Technology Corporation

For more information about this report visit https://www.researchandmarkets.com/r/7wfidi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

South Korea Colocation Data Center Portfolio Analysis Report 2025-2028: Existing & Upcoming White-Floor Space, Current and Future IT Load Capacity, Wholesale and Retail Colocation Pricing - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "South Korea Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. South Korea's upcoming data center pipeline is heavily concentrated around Seoul, led by hyperscale and telecom operators, with multiple 100MW+ mega-campuses under development. South Korea hosts around 58 operational data centers with a combined IT load capacity of approximately 850 MW. The top three operators - LG Uplus, KT Cloud, and SK broadba...

Growth Opportunities in Digital Logistics: Set to Exceed a Market Valuation of $85 Billion by 2030, Booming at 25% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Digital Logistics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Digital Logistics Market will grow from USD 22.30 Billion in 2024 to USD 85.07 Billion by 2030 at a 25% CAGR. Main drivers include the exponential growth of e-commerce, which demands faster and more transparent delivery, and the increasing need for real-time supply chain oversight. Key Market Drivers...

The Global T-cell Therapy Market 2025-2030 by Therapy Type, Indication and Region - Shift Towards Allogeneic Platforms to Boost Market Accessibility - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "T-cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global T-cell Therapy Market, valued at USD 2.92 Billion in 2024, is projected to experience a CAGR of 9.90% to reach USD 5.14 Billion by 2030. The market's expansion is significantly propelled by the increasing global prevalence of various cancers, continuous technological advancements in genetic engineering...
Back to Newsroom